Genetron Limited (GTH)
NASDAQ: GTH
· Real-Time Price · USD
4.03
0.01 (0.25%)
At close: Mar 28, 2024, 9:00 PM
Genetron Revenue Breakdown
| Period Ending | Dec 31, 2022 |
|---|---|
| Development services Revenue | 48.1M |
| Development services Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 197.28M | 197.28M | 154.83M | 141.09M | 165.19M | 157.61M | 143.09M | 104.27M | 116.31M | 93M | 88.52M | 75.45M | 97.71M | 99.13M | 93.1M | 80.79M | 93.33M |
| Selling, General, and Administrative Revenue Growth | 0.00% | +27.42% | +9.74% | -14.59% | +4.81% | +10.14% | +37.23% | -10.35% | +25.07% | +5.05% | +17.33% | -22.78% | -1.44% | +6.48% | +15.23% | -13.44% | n/a |
| Research and Development Revenue | 74.54M | 74.54M | 61.64M | 79.56M | 85.45M | 62.36M | 56.16M | 49.97M | 52.97M | 38.56M | 29.84M | 27.63M | 32.36M | 20.75M | 19.17M | 19.42M | 21.15M |
| Research and Development Revenue Growth | 0.00% | +20.93% | -22.52% | -6.89% | +37.02% | +11.04% | +12.38% | -5.65% | +37.38% | +29.19% | +8.02% | -14.62% | +55.94% | +8.26% | -1.28% | -8.22% | n/a |
| Sales and Marketing Revenue | 89.51M | 89.51M | 94.69M | 90.84M | 100.35M | 94.63M | 88.52M | 59.67M | 71.96M | 60.56M | 60.62M | 53.82M | 69.01M | 65.72M | 65.25M | 53.59M | 62.42M |
| Sales and Marketing Revenue Growth | 0.00% | -5.47% | +4.24% | -9.47% | +6.05% | +6.90% | +48.34% | -17.08% | +18.83% | -0.10% | +12.62% | -22.00% | +5.01% | +0.72% | +21.77% | -14.15% | n/a |